Xwpharma Ltd.
USPTO PatentsView assignee record - 26 granted patents across 7 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Xwpharma ranks #11,879 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 7 technology areas.
- #11,879
- of 49,997 US assignees by volume
- Top 12%
- by Innovation Score (50.9/100)
- 17.0
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R11879 · Foreign Corporation #11,879 · 26 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-SMALL 26 grants
- UPPER-Q #11,879/49,997
- PHOTO-FINISH Xcom Labs
- CPC-NARROW A61K · 7 areas
- INNOV-PAR 50.9/100
- CLAIMS-RICH 17.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2021–2025 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Xcom Labs, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Xwpharma’s 50.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Xwpharma
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Dispensing Dynamics… · near
Dispensing Dynamics… · near
51 score
- McAlister · near
McAlister · near
51 score
- Ojjo · near
Ojjo · near
51 score
- Taiyo Nippon Sanso · near
Taiyo Nippon Sanso · near
51 score
- Xwpharma · this assignee
Xwpharma · this assignee
51 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Xwpharma's Innovation Score is 50.9/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Xwpharma?
Each dot is one of Xwpharma’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Xwpharma’s own 17.0 claims/patent is ABOVE the 14.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Xwpharma's grants concentrate
Xwpharma Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 80.8% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (9 grants) versus a trough of 1 in 2021. By volume, Xwpharma sits between Xcom Labs, Inc. and Yazaki Energy System Corporation.
Xwpharma's three-year grant acceleration
Xwpharma Ltd. shows 20 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Xwpharma's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Xcom Labs
Xcom Labs, Inc.
26 patents
- XL Hybrids
XL Hybrids
26 patents
- Xrspace
Xrspace Co., Ltd.
26 patents
- Xuanzhu Pharma
Xuanzhu Pharma Co., Ltd.
26 patents
- Xylo
Xylo Technologies AG
26 patents
- Xuzhou Heavy Mach…
Xuzhou Heavy Machinery Co., Ltd.
26 patents
- Yaskawa America
Yaskawa America, Inc.
26 patents
- Yazaki Energy Sys…
Yazaki Energy System Corporation
26 patents
- Xwpharma ◀
Xwpharma Ltd.
26 patents
What this shows Xwpharma holds 26 patents at rank #11,878, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Xwpharma
By rank, the assignees closest to #11,878 in granted patent volume.
- Xcom Labs, Inc. #11,874 · 26 patents
- XL Hybrids #11,875 · 26 patents
- Xrspace Co., Ltd. #11,876 · 26 patents
- Xuanzhu Pharma Co., Ltd. #11,877 · 26 patents
- Xylo Technologies AG #11,879 · 26 patents
- Xuzhou Heavy Machinery Co., Ltd. #11,880 · 26 patents
- Yaskawa America, Inc. #11,881 · 26 patents
- Yazaki Energy System Corporation #11,882 · 26 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Xwpharma's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Xwpharma, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Xwpharma ranks #1,078 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (51 here).
Xwpharma's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 3.8% |
| 2022 | 9 | 34.6% |
| 2023 | 5 | 19.2% |
| 2024 | 6 | 23.1% |
| 2025partial year | 5 | 19.2% |
Which technologies does Xwpharma Ltd. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Xwpharma Ltd.'s patent record in context - here's where to go next.
- Xwpharma Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 80.8% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #11,879 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Xwpharma Ltd. against Xcom Labs, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 50.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.